2,6-Bis(1H-benzo[d]imidazol-1-yl)pyridine

Catalog No.: 
ACTUPK795
CAS No.: 
1030366-99-4
Molecular Formula: 
C19H13N5
Molecular Weight: 
311.35
2,6-Bis(1H-benzo[d]imidazol-1-yl)pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$326.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,6-Bis(1H-benzo[d]imidazol-1-yl)pyridine
IUPAC Name2,6-bis(1H-benzo[d]imidazol-1-yl)pyridine
Molecular FormulaC19H13N5
Molecular Weight311.35
SMILESC1(N2C=NC3=CC=CC=C23)=NC(N4C=NC5=CC=CC=C45)=CC=C1
InChI KeyLVJJGIRQDSXHEU-UHFFFAOYSA-N
Synonym2,6-bis(benzoiMidazo-1-ly)pyridin;2,6-Bis(1H-benzo[d]iMidazol-1-yl)pyridine;1H-Benzimidazole, 1,1'-(2,6-pyridinediyl)bis-
CAS No.1030366-99-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352+P332+P313+P362+P364-P305+P351+P338+P337+P313

Synthetic Route by SureRoute

1. ACTUPK795 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACASQM480 route compound structure diagram
    ACASQM48024304-54-9In Stock
  4. Then
  5. ACTUPK795 route product structure diagram
    ACTUPK7951030366-99-4
Inquiry

2. ACTUPK795 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEDMW612 route compound structure diagram
    ACEDMW6126108-23-2In Stock
  4. Then
  5. ACTUPK795 route product structure diagram
    ACTUPK7951030366-99-4
Inquiry

3. ACTUPK795 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTUPK795 route product structure diagram
    ACTUPK7951030366-99-4
Inquiry

Comments (0)